Các chỉ số sinh học về sự tiếp xúc và tác hại tiềm tàng ở người sử dụng thuốc lá điện tử độc quyền và những người hút thuốc hiện tại, đã từng hút và chưa bao giờ hút thuốc

US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General. Atlanta (GA). 2014. Perfetti T, Rodgman A (2011) The complexity of tobacco and tobacco smoke. Beitr Tab Int/Contrib Tob Res 24:215–232. https://doi.org/10.2478/cttr-2013-0902 FDA. Harmful and Potentially Harmful Constituents in Tobacco Products and Tobacco Smoke: Established List. 2012. Available from: https://www.fda.gov/tobacco-products/rules-regulations-and-guidance/harmful-and-potentially-harmful-constituents-tobacco-products-and-tobacco-smoke-established-list. Doll R, Peto R, Wheatley K, Gray R, Sutherland I (1994) Mortality in relation to smoking: 40 years’ observations on male British doctors. BMJ 309(6959):901–911. https://doi.org/10.1136/bmj.309.6959.901 Institute of Medicine (US). Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction (Stratton K, Shetty P, Wallace R, Bondurant S, editors). Washington (DC): National Academies Press 2001. IARC (2007) IARC monographs on the evaluation of carcinogenic risks to humans. Smokeless tobacco and some tobacco-specific N-nitrosamines 89:1–592 Popa C (2015) Infrared spectroscopy study of the influence of inhaled vapors/smoke produced by cigarettes of active smokers. J Biomed Opt 20(5):051003. DOI: https://doi.org/10.1117/1.JBO.20.5.051003. Rehan HS, Maini J, Hungin APS (2018) Vaping versus smoking: a quest for efficacy and safety of e-cigarette. Curr Drug Saf 13(2):92–101. https://doi.org/10.2174/1574886313666180227110556 WHO Report on the Global Tobacco Epidemic, 2011: Warning about the dangers of tobacco. World Health Organization. 2011. WHO Report on the Global Tobacco Epidemic, 2021: Addressing new and emerging products. World Health Organization. 2021. US Department of Health and Human Services. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. A Report of the Surgeon General. 2010. Report No.: QV137H8472010. Fearon IM, Phillips G, Carr T, Taylor M, Breheny D, Faux SP (2011) The role of oxidative stress in smoking-related diseases. Mini-Rev Org Chem 8(4):360–371. https://doi.org/10.2174/157019311797440317 Cunningham A, McAdam K, Thissen J, Digard H (2020) The Evolving E-cigarette: Comparative Chemical Analyses of E-cigarette Vapor and Cigarette Smoke. Front Toxicol 2. DOI: https://doi.org/10.3389/ftox.2020.586674. Farsalinos KE, Gillman G (2017) Carbonyl emissions in e-cigarette aerosol: a systematic review and methodological considerations. Front Physiol 8:1119. https://doi.org/10.3389/fphys.2017.01119 Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J et al (2014) Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control 23(2):133–139. https://doi.org/10.1136/tobaccocontrol-2012-050859 Margham J, McAdam K, Forster M, Liu C, Wright C, Mariner D et al (2016) Chemical composition of aerosol from an e-cigarette: a quantitative comparison with cigarette smoke. Chem Res Toxicol 29(10):1662–1678. https://doi.org/10.1021/acs.chemrestox.6b00188 Nicol J, Fraser R, Walker L, Liu C, Murphy J, Proctor CJ (2020) Comprehensive chemical characterization of the aerosol emissions of a vaping product based on a new technology. Chem Res Toxicol 33(3):789–799. https://doi.org/10.1021/acs.chemrestox.9b00442 Pinto MI, Thissen J, Hermes N, Cunningham A, Digard H, Murphy J (2022) Chemical characterisation of the vapour emitted by an e-cigarette using a ceramic wick-based technology. Sci Rep 12(1):16497. https://doi.org/10.1038/s41598-022-19761-w Royal College of Physicians. Nicotine without smoke: Tobacco harm reduction. 2016. Royal College of General Practitioners Position statement on the use of electronic nicotine vapour products (E-Cigarettes). 2017. Public Health England Guidance. Health matters: stopping smoking – what works? 2019. McNeill A, Brose L, Calder R, Hitchman S (2015) E-cigarettes: an evidence update. A report commissioned by Public Health England, London Cancer Research UK. E-cigarettes Safer than Smoking Says Long-term Study. 2017. Available from: https://news.cancerresearchuk.org/2017/02/06/e-cigarettes-safer-than-smoking-says-long-term-study/. Brose LS, Hitchman SC, Brown J, West R, McNeill A (2015) Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction 110(7):1160–1168. https://doi.org/10.1111/add.12917 Brown J, Beard E, Kotz D, Michie S, West R (2014) Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 109(9):1531–1540. https://doi.org/10.1111/add.12623 Shahab L, Goniewicz ML, Blount BC, Brown J, McNeill A, Alwis KU et al (2017) Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann Intern Med 166(6):390–400. https://doi.org/10.7326/M16-1107 Cohen G, Goldenson NI, Bailey PC, Chan S, Shiffman S (2021) Changes in biomarkers of cigarette smoke exposure after 6 days of switching exclusively or partially to use of the JUUL system with two nicotine concentrations: a randomized controlled confinement study in adult smokers. Nicotine Tob Res 23(12):2153–2161. https://doi.org/10.1093/ntr/ntab134 Jay J, Pfaunmiller EL, Huang NJ, Cohen G, Graff DW (2020) Five-day changes in biomarkers of exposure among adult smokers after completely switching from combustible cigarettes to a nicotine-salt pod system. Nicotine Tob Res 22(8):1285–1293. https://doi.org/10.1093/ntr/ntz206 McEwan M, Gale N, Ebajemito JK, Camacho OM, Hardie G, Proctor CJ et al (2021) A randomized controlled study in healthy participants to explore the exposure continuum when smokers switch to a tobacco heating product or an E-cigarette relative to cessation. Toxicol Rep 8:994–1001. https://doi.org/10.1016/j.toxrep.2021.05.003 Morris P, McDermott S, Chapman F, Verron T, Cahours X, Stevenson M et al (2021) Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu() electronic nicotine delivery systems (ENDS). Intern Emerg Med. https://doi.org/10.1007/s11739-021-02813-w Round EK, Chen P, Taylor AK, Schmidt E (2019) Biomarkers of tobacco exposure decrease after smokers switch to an e-cigarette or nicotine gum. Nicotine Tob Res 21(9):1239–1247. https://doi.org/10.1093/ntr/nty140 Oliveri D, Liang Q, Sarkar M (2019) Real-world evidence of differences in biomarkers of exposure to select harmful and potentially harmful constituents and biomarkers of potential harm between adult e-vapor users and adult cigarette smokers. Nicotine Tob Res 22(7):1114–1122. https://doi.org/10.1093/ntr/ntz185 Smith DM, Shahab L, Blount BC, Gawron M, Kosminder L, Sobczak A, et al. (2020) Differences in Exposure to Nicotine, Tobacco-Specific Nitrosamines, and Volatile Organic Compounds among Electronic Cigarette Users, Tobacco Smokers, and Dual Users from Three Countries. Toxics 8(4). DOI: https://doi.org/10.3390/toxics8040088. Chang CM, Cheng YC, Cho TM, Mishina EV, Del Valle-Pinero AY, van Bemmel DM et al (2019) Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop. Nicotine Tob Res 21(1):3–13. https://doi.org/10.1093/ntr/ntx273 Institute of Medicine (2012) Scientific standards for studies on modified risk tobacco products. The National Academies Press, Washington, DC FDA. Modified Risk Tobacco Product Applications. Draft Guidance for Industry2012. Gale N, Haswell LE, McEwan M, Azzopardi D, Thissen J, Hardie G (2022) Biomarkers of exposure and potential harm in exclusive users of electronic cigarettes and current, former and never-smokers: a cross-sectional study protocol. Journal of Health and Environmental Research 8(2):116–127. https://doi.org/10.11648/j.jher.20220802.17 Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P, Jarvis MJ et al (2020) Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tob Res 22(7):1086–1097. https://doi.org/10.1093/ntr/ntz132 Camacho OM, McEwan M, Gale N, Pluym N, Scherer M, Hardie G, et al. (2021) Use of the Acrylonitrile Haemoglobin Adduct N‑(2‑cyanoethyl)valine as a Biomarker Of Compliance in Smokers Switching to Tobacco Heating Products. Preprints 2021080085. DOI: https://doi.org/10.20944/preprints202108.0085.v1. Hays RD, Sherbourne CD, Mazel RM (1993) The RAND 36-Item Health Survey 1.0. Health Econ 2(3):217–227. DOI: https://doi.org/10.1002/hec.4730020305. Scherer G, Newland K, Papadopoulou E, Minet E (2014) A correlation study applied to biomarkers of internal and effective dose for acrylonitrile and 4-aminobiphenyl in smokers. Biomarkers 19(4):291–301. https://doi.org/10.3109/1354750X.2014.910271 Gale N, McEwan M, Camacho OM, Hardie G, Proctor CJ, Murphy J (2021) Changes in biomarkers after 180 days of tobacco heating product use: a randomised trial. Intern Emerg Med. https://doi.org/10.1007/s11739-021-02798-6 WHO Study Group on Tobacco Regulation. Report on the Scientific Basis of Tobacco Product Regulation: Fifth Report of a WHO Study Group. 2015. Gale N, McEwan M, Eldridge AC, Sherwood N, Bowen E, McDermott S et al (2017) A randomised, controlled, two-Centre open-label study in healthy Japanese subjects to evaluate the effect on biomarkers of exposure of switching from a conventional cigarette to a tobacco heating product. BMC Public Health 17(1):673. https://doi.org/10.1186/s12889-017-4678-9 Rögner N, Hagedorn H-W, Scherer G, Scherer M, Pluym N (2021) A Sensitive LC–MS/MS method for the quantification of 3-Hydroxybenzo[a]pyrene in urine-exposure assessment in smokers and users of potentially reduced-risk products. Separations 8(10):171. https://doi.org/10.3390/separations8100171 Yuan JM, Butler LM, Stepanov I, Hecht SS (2014) Urinary tobacco smoke-constituent biomarkers for assessing risk of lung cancer. Cancer Res 74(2):401–411. https://doi.org/10.1158/0008-5472.CAN-13-3178 Hecht S, Murphy S, Stepanov I, Nelson H, Yuan J-M (2012) Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai cohort study. Cancer Lett 334(1):34–38. https://doi.org/10.1016/j.canlet.2012.07.016 Xue J, Yang S, Seng S (2014) Mechanisms of cancer induction by tobacco-specific NNK and NNN. Cancers (Basel) 6(2):1138–1156. https://doi.org/10.3390/cancers6021138 Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. (2019) Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J Respir Crit Care Med 200(8):e70-e88. DOI: https://doi.org/10.1164/rccm.201908-1590ST. Haswell LE, Papadopoulou E, Newland N, Shepperd CJ, Lowe FJ (2014) A cross-sectional analysis of candidate biomarkers of biological effect in smokers, never-smokers and ex-smokers. Biomarkers 19(5):356–367. https://doi.org/10.3109/1354750X.2014.912354 Hatsukami DK, Meier E, Lindgren BR, Anderson A, Reisinger SA, Norton KJ et al (2020) A randomized clinical trial examining the effects of instructions for electronic cigarette use on smoking-related behaviors and biomarkers of exposure. Nicotine Tob Res 22(9):1524–1532. https://doi.org/10.1093/ntr/ntz233 Shahab L, Goniewicz ML, Blount BC, Brown J, West R (2017) E-cigarettes and toxin exposure. Ann Intern Med 167(7):525–526. https://doi.org/10.7326/L17-0315 Wilson N, Summers JA, Ait Ouakrim D, Hoek J, Edwards R, Blakely T (2021) Improving on estimates of the potential relative harm to health from using modern ENDS (vaping) compared to tobacco smoking. BMC Public Health 21(1):2038. https://doi.org/10.1186/s12889-021-12103-x Wilson N, Summers JA, Ouakrim DA, Hoek J, Edwards R, Blakely T (2022) Correction: Improving on estimates of the potential relative harm to health from using modern ENDS (vaping) compared to tobacco smoking. BMC Public Health 22(1):1788. https://doi.org/10.1186/s12889-022-13983-3 E-cigarettes and heated tobacco products: evidence review. Public Health England; 2018. Available from: https://www.gov.uk/government/publications/e-cigarettes-and-heated-tobacco-products-evidence-review. McNeill A, Simonavičius E, Brose L, Taylor E, East K, Zuikova E, et al. Nicotine vaping in England: an evidence update including health risks and perceptions. 2022. Eissenberg T, Bhatnagar A, Chapman S, Jordt SE, Shihadeh A, Soule EK (2020) Invalidity of an oft-cited estimate of the relative harms of electronic cigarettes. Am J Public Health 110(2):161–162. https://doi.org/10.2105/AJPH.2019.305424.[InlineImageRemoved]